Hospital Acquired Infection Control Market by Type (Diagnostic & Testing Equipment, Disinfection Products, Hand Hygiene Products), Indication (Bloodstream Infections, Clostridioides difficile Infections, Hospital-acquired Pneumonia), End-user - Global For

Hospital Acquired Infection Control Market by Type (Diagnostic & Testing Equipment, Disinfection Products, Hand Hygiene Products), Indication (Bloodstream Infections, Clostridioides difficile Infections, Hospital-acquired Pneumonia), End-user - Global Forecast 2024-2030

The Hospital Acquired Infection Control Market size was estimated at USD 34.26 billion in 2023 and expected to reach USD 36.39 billion in 2024, at a CAGR 6.48% to reach USD 53.20 billion by 2030.

Hospital acquired infection (HAI) control refers to the systematic approach and dedicated efforts undertaken by healthcare institutions to prevent and manage infections acquired by patients during their stay in hospitals & other healthcare facilities. These infections can occur as a result of exposure to various microbial agents, including bacteria, viruses, fungi, and other pathogens. The control measures span a wide range of strategies, including rigorous hygiene practices, sterilization and disinfection procedures, use of personal protective equipment (PPE), surveillance of infections, and adherence to protocols for invasive procedures and antibiotic stewardship. The rising awareness about infections acquired in healthcare settings, coupled with a rapidly growing emphasis on infection control policies, boosts the market growth. However, high costs associated with advanced infection control technologies can be prohibitive for resource-limited settings. Furthermore, technological advancements in sterilization and disinfection processes, along with the development of eco-friendly and more efficient disinfectants, pose significant opportunities to the manufacturers.

Please Note: PDF & Excel + Online Access - 1 Year